Literature DB >> 3129727

Soluble interleukin 2 receptors are released from the cell surface of normal murine B lymphocytes stimulated with interleukin 5.

M S Loughnan1, C J Sanderson, G J Nossal.   

Abstract

Murine T and B lymphocytes can be induced to release soluble interleukin 2 receptors (IL2Rs). This receptor is believed to be a truncated form of the 55-kDa chain of the cell-membrane-associated receptor. It has been speculated that this receptor may play an important immunoregulatory role by binding to interleukin 2 (IL-2). We report here that interleukin 5 can induce normal murine B cells to release soluble IL2Rs. This extends our finding that interleukin 5 similarly can induce murine B cells to express functional cell-surface-associated IL2Rs. Two possible mechanisms of release of soluble IL2Rs have been suggested. Soluble IL2R could be synthesized as a secretory form of the receptor lacking the transmembrane domain or by cleavage of the extracellular domain of the cell-surface-associated IL2R at the cell surface. To investigate which mechanism was operative, we radioiodinated the cell surface of normal murine splenocytes that had been cultured for 1 day with Con A to stimulate the expression of cell-surface-associated IL2Rs and the release of soluble IL2Rs. Under the conditions used, radiolabeling of internal proteins was not apparent. Labeled cells were then recultured with Con A, conditioned medium was taken from replicate cultures at various times after radioiodination, and the specific radioactivity of released soluble IL2Rs was determined by ELISA and RIA. We demonstrate that the specific radioactivity and the kinetics of change of the specific radioactivity are consistent with the hypothesis that the soluble IL2Rs are derived from the cell-surface-associated IL2Rs rather than being released in a secretory form.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3129727      PMCID: PMC280154          DOI: 10.1073/pnas.85.9.3115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Interleukin 2 receptors are released by cells in vitro and in vivo. I. Detection of soluble IL 2 receptors in cell culture supernatants and in the serum of mice by an immunoradiometric assay.

Authors:  H Osawa; O Josimovic-Alasevic; T Diamantstein
Journal:  Eur J Immunol       Date:  1986-04       Impact factor: 5.532

Review 2.  Biochemistry of the glycosyl-phosphatidylinositol membrane protein anchors.

Authors:  M G Low
Journal:  Biochem J       Date:  1987-05-15       Impact factor: 3.857

3.  Phosphatidylinositol is the membrane-anchoring domain of the Thy-1 glycoprotein.

Authors:  M G Low; P W Kincade
Journal:  Nature       Date:  1985 Nov 7-13       Impact factor: 49.962

4.  Photoaffinity labeling of insulin receptors in viable cultured human lymphocytes. Demonstration of receptor shedding and degradation.

Authors:  P Berhanu; J M Olefsky
Journal:  Diabetes       Date:  1982-05       Impact factor: 9.461

5.  Proliferation and differentiation of single hapten-specific B lymphocytes is promoted by T-cell factor(s) distinct from T-cell growth factor.

Authors:  B L Pike; D L Vaux; I Clark-Lewis; J W Schrader; G J Nossal
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

6.  Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

Authors:  L A Rubin; C C Kurman; M E Fritz; W E Biddison; B Boutin; R Yarchoan; D L Nelson
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

7.  T cell growth factor receptors. Quantitation, specificity, and biological relevance.

Authors:  R J Robb; A Munck; K A Smith
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

8.  Mechanism of effector-cell blockade. I. Antigen-induced suppression of Ig synthesis in a hybridoma cell line, and correlation with cell-associated antigen.

Authors:  A W Boyd; J W Schrader
Journal:  J Exp Med       Date:  1980-06-01       Impact factor: 14.307

9.  Expression of Tac antigen on activated normal human B cells.

Authors:  M Tsudo; T Uchiyama; H Uchino
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

10.  Activated B cells express receptors for, and proliferate in response to, pure interleukin 2.

Authors:  R H Zubler; J W Lowenthal; F Erard; N Hashimoto; R Devos; H R MacDonald
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

View more
  18 in total

1.  Native avian c-erbB gene expresses a secreted protein product corresponding to the ligand-binding domain of the receptor.

Authors:  N J Maihle; T W Flickinger; M A Raines; M L Sanders; H J Kung
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

2.  Changes in insulin-receptor structure associated with trypsin-induced activation of the receptor tyrosine kinase.

Authors:  S Clark; G Eckardt; K Siddle; L C Harrison
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

3.  Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease.

Authors:  Veeral Ajmera; Emily R Perito; Nathan M Bass; Norah A Terrault; Katherine P Yates; Ryan Gill; Rohit Loomba; Anna Mae Diehl; Bradley E Aouizerat
Journal:  Hepatology       Date:  2016-10-12       Impact factor: 17.425

4.  Soluble interleukin-2 receptor and soluble CD8 in liver cirrhosis and obstructive jaundice.

Authors:  F Wagner; C Assemi; C Lersch; R Hart; M Classen
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

5.  The serum cytokine profiles of lymphoma-associated hemophagocytic syndrome: a comparative analysis of B-cell and T-cell/natural killer cell lymphomas.

Authors:  Tatsuharu Ohno; Yasunori Ueda; Ken-ichi Nagai; Takayuki Takahashi; Yoshiteru Konaka; Teruyuki Takamatsu; Takayo Suzuki; Masataka Sasada; Takashi Uchiyama
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

6.  A truncated intracellular HER2/neu receptor produced by alternative RNA processing affects growth of human carcinoma cells.

Authors:  G K Scott; R Robles; J W Park; P A Montgomery; J Daniel; W E Holmes; J Lee; G A Keller; W L Li; B M Fendly
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

7.  Elevated soluble IL-2Rα, IL-8, and MIP-1β levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphoma.

Authors:  Mohamad B Sonbol; Matthew J Maurer; Mary J Stenson; Cristine Allmer; Betsy R LaPlant; George J Weiner; William R Macon; James R Cerhan; Thomas E Witzig; Mamta Gupta
Journal:  Am J Hematol       Date:  2014-09-19       Impact factor: 10.047

8.  Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships.

Authors:  N El Houda Agueznay; C Badoual; S Hans; A Gey; B Vingert; S Peyrard; F Quintin-Colonna; P Ravel; P Bruneval; S Roncelin; B Lelongt; J Bertoglio; W H Fridman; D Brasnu; E Tartour
Journal:  Clin Exp Immunol       Date:  2007-08-03       Impact factor: 4.330

Review 9.  The nerve growth factor receptor: a multicomponent system that mediates the actions of the neurotrophin family of proteins.

Authors:  P A Barker; R A Murphy
Journal:  Mol Cell Biochem       Date:  1992-03-04       Impact factor: 3.396

10.  Interleukin-2 receptors in experimental Chagas' disease.

Authors:  D R Pakianathan; R E Kuhn
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.